RXC007
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Redx Pharma Ltd
Overview
RXC007 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
RXC007 clinical trials
Explore related
Medical disclaimer. This page summarizes research about RXC007 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.